New dextran coated activated carbons for medical use
| dc.contributor.author | Howell, C. A. | |
| dc.contributor.author | Sandeman, S. R. | |
| dc.contributor.author | Zheng, Y. | |
| dc.contributor.author | Mikhalovsky, S. V. | |
| dc.contributor.author | Nikolaev, V. G. | |
| dc.contributor.author | Sakhno, L. A. | |
| dc.contributor.author | Snezhkova, E. A. | |
| dc.date.accessioned | 2017-01-06T10:52:48Z | |
| dc.date.available | 2017-01-06T10:52:48Z | |
| dc.date.issued | 2016-02-01 | |
| dc.description.abstract | Activated carbon (AC) can be used for blood purification (hemoperfusion) to treat a range of conditions by direct perfusion of blood through an adsorbent column. The clinical effects of hemoperfusion relate to the AC adsorptive capacity, and any inflammatory response generated by direct blood contact. | ru_RU |
| dc.identifier.citation | Howell, C. A., Sandeman, S. R., Zheng, Y., Mikhalovsky, S. V., Nikolaev, V. G., Sakhno, L. A., & Snezhkova, E. A. (2016). New dextran coated activated carbons for medical use. Carbon, 97, 134-146. DOI: 10.1016/j.carbon.2015.09.042 | ru_RU |
| dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/2197 | |
| dc.language.iso | en | ru_RU |
| dc.publisher | Carbon | ru_RU |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
| dc.subject | carbon | ru_RU |
| dc.subject | Research Subject Categories::TECHNOLOGY::Engineering physics | ru_RU |
| dc.title | New dextran coated activated carbons for medical use | ru_RU |
| dc.type | Article | ru_RU |